Advertisement

Topics

Wyeth Company Profile

12:19 EDT 23rd June 2018 | BioPortfolio

Wyeth is a research-based, global pharmaceutical company responsible for the discovery and development of some of today's most innovative medicines. Our products are sold in more than 140 countries, and our product portfolio includes innovative treatments across a wide range of therapeutic areas. Our worldwide resources include more than 52,000 employees, manufacturing facilities on five continents, and a discovery and development platform encompassing pharmaceuticals, vaccines and biotechnology

Location

5 Giralda Farms
Madisson
NJ
07940
United States of America


News Articles [11 Associated News Articles listed on BioPortfolio]

Pfizer and Wyeth’s $68bn Deal

Is the Pfizer and Wyeth deal a good move? Does this provide opportunities for other big pharma in 2009? Tibor Papp and Kevin Bottomley of PharmaVentures answer these questions and more in this specia...

Thiakis’ origins, Bloom and acquisition by Wyeth

Dr Fintan Walton talks with Dr John Burt, former CEO of Thiakis, about: • the company’s origins and specific technology • the work of Professor Steve Bloom at Imperial College • obesity treat...

Robert A. Essner, former Chairman and Chief Executive of Wyeth, named Executive Chairman of ...

NEW YORK, NY--(Marketwired - April 25, 2018) -ELUCIDA ONCOLOGY, INC ®, a biotechnology company focused on developing and commercializing a first-in-class, ultra-small Read more...

PTV News: Oct 16, 2009

Top stories on October 16th, 2009: Closure: the Pfizer-Wyeth effect on jobs and drug discovery Baxter: strong earnings, flat sales Going cheap - the big pharmamanufacturing sell-off Survival ...

PTV News: Oct 15, 2009

Top stories on October 15th, 2009: Tamiflu fuels Roche Q3 success story Steps forward in MS as Acorda drug pleases FDA advisors Progenics regains Relistor rights from Wyeth Phytopharm soars o...

PTV News: Aug 25, 2009

Top stories on August 25th, 2009: FDA Approves Lunbeck's drug for infantile spasms RNA specialist Santaris forms an alliance with Shire A...

Pfizer: An Ideal Development Partner

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Doug Giordano, Vice President, Business Development at Pfizer. Filmed at BIO-Europe 2009, they discuss: • the strategy behind...

BioTime Appoints Cavan Redmond to Its Board of Directors

Former CEO of WebMD, former General Manager of Wyeth Biopharma and Group President of Pfizer 30 Years of Executive Management and Corporate Strategy Ex...

Drugs and Medications [88 Associated Drugs and Medications listed on BioPortfolio]

Chapstick moisturizer [Wyeth Consumer Healthcare]

ChapStick Moisturizer(octinoxate, oxybenzone, white petrolatum)

Preparation h cooling gel [Wyeth Consumer Healthcare]

Preparation H Cooling Gel (phenylephrine HCl and witch hazel)

Childrens dimetapp nighttime cold and congestion [Richmond Division of Wyeth LLC, a subsidiary of Pfizer Inc.]

Children’s Dimetapp Nighttime Cold & Congestion(diphenhydramine HCl and phenylephrine HCl)

Alavert allergy sinus d-12 [Wyeth Consumer Healthcare]

Alavert D-12 Hour Allergy and Sinus (Extended Release Tablets)(loratadine and pseudoephedrine sulfate)

Dristan 12 hr nasal spray [Wyeth Consumer Healthcare]

Dristan 12-hr Nasal Spray(oxymetazoline hydrochloride)

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

An Open-Label Positron Emission Tomography (PET) Study to Evaluate Serotonin Transporter Occupancy Following Escalating Dosing Regimens of (R)-(-)-O-desmethylvenlafaxine and Racemic O-Desmethylvenlafaxine.

SEP-227162 [R(-)-O-desmethylvenlafaxine] is an enantiomer of the venlafaxine metabolite O-desmethylvenlafaxine (ODV, Pristiq™, Wyeth). This study compared the serotonin transporter occupancy achieve...

Secondary patents in the pharmaceutical industry: Missing the wood for the trees?

Introduction The critics of the Innovator pharmaceutical industry allege that secondary patents are trivial modifications over the primary patent, which extend its term and delay the entry of the gene...

Clinical Trials [33 Associated Clinical Trials listed on BioPortfolio]

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

The purpose of this Phase IIIb study is to evaluate the immunogenicity, reactogenicity & safety of GSK Biologicals' Hib-MenC vaccine (Menitorix™) when co-administered with GSK Biological...

Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg

The objective of this study was to investigate the bioequivalence of Mylan's lorazepam 2 mg tablets to Wyeth's Ativan 2 mg tablets following a single, oral 2 mg (1 x 2 mg) dose administere...

Post-Marketing Safety Study of GSK Biological's Pediarix™ Vaccine.

Pre-licensure studies of GSK Biologicals' PEDIARIX vaccine have shown it to be generally safe and unlikely to result in vaccine-associated serious adverse events. This post-licensure study...

Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar

The present study intends to investigate the use as a booster of a dose of sanofi pasteur's Pneumo 23 vaccine in the second year of life following 3-dose priming with Wyeth's Prevnar vacci...

Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition

To determine the single-dose oral bioequivalence study of Ibuprofen and Diphenhydramine citrate 200 mg/38 mg caplets of Dr. Reddy's Laboratories Limited, India and Advil®PM, of Wyeth cons...

Companies [28 Associated Companies listed on BioPortfolio]

Wyeth Pharmaceuticals, Wyeth

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplanta...

Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation...

Wyeth Nutrition

For the past 100 years, Wyeth Nutrition has pioneered innovative nutrition science with premium-quality products that meet the needs of infants, young children and adults. Through...

Wyeth

Wyeth is a research-based, global pharmaceutical company responsible for the discovery and development of some of today's most innovative medicines. Our products are sold in more than 140 countries, a...

Profectus BioSciences Inc.

Enabled by an experienced development team and two propriety platform technologies in-licensed from Wyeth Vaccines (now Pfizer, Inc.), Profectus BioSciences Inc. is developing the...

More Information about "Wyeth" on BioPortfolio

We have published hundreds of Wyeth news stories on BioPortfolio along with dozens of Wyeth Clinical Trials and PubMed Articles about Wyeth for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Wyeth Companies in our database. You can also find out about relevant Wyeth Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record